Category: News

Rosenberger Hochfrequenztechnik to Exhibit at Mobile World Congress 2016, booth 6G37

FRIDOLFING, Germany–(BUSINESS WIRE)–Press Kit Materials are Available at: http://www.tradeshownews.com/events/mobile-world-congress-2016/Rosenberger-Hochfrequenztechnik/ Company:   Rosenberger Hochfrequenztechnik Booth/Stand: 6G37 Event: Mobile World Congress 2016Feb 22 – 25, 2016Barcelona, ES Web: http://www.rosenberger.com Facebook: https://www.facebook.com/Rosenberger.HFT About Rosenberger Hochfrequenztechnik Rosenberger is one of the worldwide leading suppliers of controlled impedance and


Bruker Reports Fourth Quarter and Fiscal Year 2015 Financial Results

BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today reported financial results for its fourth quarter ended December 31, 2015. Bruker’s revenues for the fourth quarter of 2015 were $478.2 million, a decline of 5.9 percent compared to revenues of $508.0 million in the fourth quarter of 2014. Excluding a 0.6 percent net negative effect from acquisitions & divestitures, and a 7.8 percent negative effect from changes in foreign exchange rates, Bruker reported year-over-ye


Aerpio Therapeutics Announces Presentation of Positive Results of AKB-9778 in Patients with Diabetic Retinopathy from TIME-2 Phase 2a Study

CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced promising results in diabetic retinopathy from the company’s phase 2a study (“TIME-2”) of its lead candidate, AKB-9778, a first-in-class Tie2 activator. AKB-9778, dosed at 15 mg BID subcutaneously, alone and in combination with Lucentis® (ranibizumab injection dosed at 0.3 mg intravitreally), improved underlying retinopathy according to


Second Sight to Present at RBC Capital Markets 2016 Global Healthcare Conference and Host Meetings at 2016 BTIG MedTech Conference

SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (“Second Sight” or “the Company”) (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Dr. Robert Greenberg, Chairman, and Will McGuire, President and Chief Executive Officer, will host one-on-one meetings and present at the following conferences this month:     Conference: RBC Capital Markets 2016 Global Healthcare Confere


Withings Now Offers Hy-Result BP Assessment Software

Withings, maker of smart scales, activity trackers, wireless blood pressure cuffs, and other devices, has released a new in-app offering to better interpret blood pressure readings. The Hy-Result algorithms were developed at the Georges Pompidou Hospital in Paris to replicate how a physician would study the numbers. In a recent study in B (Read more...)

Spectranetics Bridge Occlusion Balloon Plugs Large Vessel Tears Caused by Lead Extractions

Spectranetics, a Colorado Springs, CO firm, won FDA 510(k) clearance for its Bridge Occlusion Balloon, a device used to block large vessels, typically the superior vena cava (SVC), if a tear happens while removing cardiac leads. Though tears are rare, when they do happen the rapid blood loss can be difficult to manage. The Bridge Occlusion [&h (Read more...)